ACYCLOVIR-INDUCED NEUROTOXICITY - CONCENTRATION-SIDE-EFFECT RELATIONSHIP IN ACYCLOVIR OVERDOSE

被引:91
作者
HAEFELI, WE [1 ]
SCHOENENBERGER, RAZ [1 ]
WEISS, P [1 ]
RITZ, RF [1 ]
机构
[1] UNIV HOSP BASEL,DEPT INTERNAL MED,DIV MED INTENS CARE,CH-4031 BASEL,SWITZERLAND
关键词
D O I
10.1016/0002-9343(93)90186-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To investigate the concentration-side effect relationship in a patient with severe acyclovir-induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir. METHODS: Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed coma and nonoliguric renal failure. The acyclovir levels measured by radioimmunoassay were related to the level of consciousness. RESULTS: We measured the highest acyclovir serum levels reported so far (229.9 mumol/L = 51.8 mg/L). Impairment of consciousness developed with a remarkable temporal delay of 24 to 48 hours after occurrence of peak serum concentrations and resolved with a comparable delay after reaching the therapeutic range (anticlockwise hysteresis). Six days after discontinuation of the drug, central nervous system symptoms had resolved, and, 4 days later, renal function returned to pretreatment values. CONCLUSIONS: The observation that neurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases. Single drug level measurements may therefore be of little diagnostic value. Since toxicity develops with a remarkable delay, early removal of the drug (by hemodialysis) could possibly prevent central nervous toxicity.
引用
收藏
页码:212 / 215
页数:4
相关论文
共 21 条
[1]   ACYCLOVIR AND NEUROLOGIC MANIFESTATIONS [J].
AUWERX, J ;
KNOCKAERT, D ;
HOFKENS, P .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) :882-883
[2]  
BATAILLE P, 1985, LANCET, V2, P724
[3]   ADVERSE-EFFECTS OF HIGH-DOSE INTRAVENOUS ACYCLOVIR IN AMBULATORY PATIENTS WITH ACUTE HERPES-ZOSTER [J].
BEAN, B ;
AEPPLI, D .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (02) :362-365
[4]  
BURGUET A, 1988, ARCH FR PEDIATR, V45, P343
[5]   SEVERE BUT REVERSIBLE NEUROTOXICITY FROM ACYCLOVIR [J].
COHEN, SMZ ;
MINKOVE, JA ;
ZEBLEY, JW ;
MULHOLLAND, JH .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (06) :920-920
[6]   DRUGS 5 YEARS LATER - ACYCLOVIR [J].
DORSKY, DI ;
CRUMPACKER, CS .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (06) :859-874
[7]   EXCESSIVE SERUM CONCENTRATIONS OF ACYCLOVIR AND NEUROTOXICITY [J].
FELDMAN, S ;
RODMAN, J ;
GREGORY, B .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (02) :385-388
[8]  
FISCHER A, 1990, SCHWEIZ MED WSCHR, V120, P1200
[9]   PHARMACOKINETICS AND SAFETY OF HIGH-DOSE ORAL ACYCLOVIR FOR SUPPRESSION OF CYTOMEGALO-VIRUS DISEASE AFTER RENAL-TRANSPLANTATION [J].
FLETCHER, CV ;
CHINNOCK, BJ ;
CHACE, B ;
BALFOUR, HH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) :158-163
[10]   NEUROTOXICITY OF ACYCLOVIR IN END STAGE RENAL-DISEASE [J].
GILL, MJ ;
BURGESS, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (02) :300-301